The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy

BACKGROUND: There are numerous non-biologic and biologic disease-modifying anti-rheumatic drugs (bDMARDs) for rheumatoid arthritis (RA). Typical sequences of bDMARDs are not clear. Future treatment policies and trials should be informed by quantitative estimates of current treatment practice. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Daniel H., Xu, Chang, Collins, Jamie, Kim, Seoyoung C., Losina, Elena, Yau, Vincent, Johansson, Fredrik D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807904/
https://www.ncbi.nlm.nih.gov/pubmed/33446261
http://dx.doi.org/10.1186/s13075-020-02408-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807904/
https://www.ncbi.nlm.nih.gov/pubmed/33446261
http://dx.doi.org/10.1186/s13075-020-02408-4

Ejemplares similares